Shares of DexCom Inc. DXCM shed 9.30% to $61.80 Thursday, on what proved to be an all-around grim trading session for the ...
Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A ...
DexCom Inc. closed 52.01% short of its 52-week high of $141.99, which the company achieved on April 9th.
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use ...
Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...
2d
Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback